Codagenix

Codagenix

Biotechnology, 3 Bioscience Park Dr, Farmingdale, New York, 11735, United States, 11-50 Employees

codagenix.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 16*********

Who is CODAGENIX

Codagenix Inc. is a clinical stage biotechnology company with vaccine products against influenza, respiratory syncytial virus, dengue virus, and others currently under development. Codage...

Read More

map
  • 3 Bioscience Park Dr, Farmingdale, New York, 11735, United States Headquarters: 3 Bioscience Park Dr, Farmingdale, New York, 11735, United States
  • 2011 Date Founded: 2011
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8071 | NAICS Code: 621511 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from CODAGENIX

Codagenix Org Chart and Mapping

Employees

Sally Yang

Associate Director Regulatory Affairs

Lori Lavoie

Senior Director Human Resources

Roger Richard

Senior Director Quality

Chen Yang

Senior Director, Early Discovery

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Codagenix

Answer: Codagenix's headquarters are located at 3 Bioscience Park Dr, Farmingdale, New York, 11735, United States

Answer: Codagenix's phone number is 16*********

Answer: Codagenix's official website is https://codagenix.com

Answer: Codagenix's revenue is $10 Million to $25 Million

Answer: Codagenix's SIC: 8071

Answer: Codagenix's NAICS: 621511

Answer: Codagenix has 11-50 employees

Answer: Codagenix is in Biotechnology

Answer: Codagenix contact info: Phone number: 16********* Website: https://codagenix.com

Answer: Codagenix Inc. is a clinical stage biotechnology company with vaccine products against influenza, respiratory syncytial virus, dengue virus, and others currently under development. Codagenix uses a computer-based algorithm, called SAVE (Synthetic Attenuated Virus Engineering) to design viral genomes that are identical to the wild type strain at the amino acid level, but make less protein in human cells. The highly attenuated viruses make excellent vaccines or oncolytics against solid tumors. Codagenix represents the next wave in vaccine technology, untethered from traditional, time-consuming and unpredictable approaches to attenuating viruses.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access